Company intelligence / Profile preview

SBI Japan-Israel Innovation Fund

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

SBI Japan-Israel Innovation Fund is an active life science-focused venture capital fund formed as a partnership between SBI Holdings (Japan) and Vertex Israel, investing in Israeli and Israel-related biopharma and high-tech companies from early to growth stages. Its portfolio covers a range of therapeutic modalities and disease areas, and includes investments in companies with clinical-stage programs targeting oncology, immunology, autoimmune diseases, microbiome, gene editing, and ophthalmology. The fund does not develop drugs itself but typically invests in firms advancing pre-clinical to mid/late-stage assets.

Modalities: Small moleculeMonoclonal antibodyAntibodyGene therapyBiologicBacteriophage-based therapy
Industry: Investors

Partnerships

VertexNovartis (via Ayala collaboration)Takeda (via LogicBio partnership)Weizmann Institute of ScienceMIT

Beyond the preview

Go deeper on SBI Japan-Israel Innovation Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBI Japan-Israel Innovation Fund.

Explore the full profile